Chikungunya virus (CHIKV), a mosquito-borne alphavirus, is the causative agent of chikungunya (CHIK) disease, a condition with low mortality but high acute and chronic morbidity resulting in high overall burden of disease. Infection rates of CHIKV have increased in recent years, and this upward trend is expected to continue as vector habitats continue to expand. This program will provide participants with key insights into CHIKV, including its epidemiology, clinical manifestations, diagnosis, current management and preventative strategies, including vaccines in development. The objective is to enable participants to enhance their knowledge of the disease and diagnostic skills, implement effective management strategies and contribute to public health efforts to protect against the virus.
This program has received an educational grant or in-kind support from Valneva.
